CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank86
5Y CAGR+114.0%
Studio
Year-over-Year Change

Price-to-sales ratio

5Y CAGR
+114.0%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
44.9x
Strong expansion
Streak
2 yr
Consecutive declineNormalizing
PeriodValueYoY Change
202553.24-65.9%
2024156.16-57.9%
2023371.36-
20220.00-100.0%
20211.28+7.8%
20201.19+20.9%
20190.98-3.8%
20181.02-1.3%
20171.03-5.8%
20161.10-